Wealthfront Advisers
TECH icon

Wealthfront Advisers’s Bio-Techne TECH Stock Holding History

Wealthfront Advisers’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$389K Buy
5,509
+549
+11% +$29.6K ﹤0.01% 932
2026
Q1 		$259K Buy
4,960
+388
+8% +$23.3K ﹤0.01% 976
2025
Q4 		$269K Buy
4,572
+728
+19% +$44.2K ﹤0.01% 953
2025
Q3 		$214K Buy
+3,844
New +$206K ﹤0.01% 969
2025
Q2 		– Sell
-3,933
Closed -$231K – 983
2025
Q1 		$231K Buy
+3,933
New +$267K ﹤0.01% 886
2023
Q1 		– Sell
-2,472
Closed -$205K – 820
2022
Q4 		$205K Buy
+2,472
New +$196K ﹤0.01% 768
2022
Q3 		– Sell
-2,996
Closed -$260K – 788
2022
Q2 		$260K Sell
2,996
-420
-12% -$39.4K ﹤0.01% 713
2022
Q1 		$370K Sell
3,416
-11,344
-77% -$1.17M ﹤0.01% 686
2021
Q4 		$1.91M Buy
14,760
+2,460
+20% +$302K 0.01% 402
2021
Q3 		$1.49M Buy
12,300
+8,056
+190% +$980K 0.01% 406
2021
Q2 		$478K Buy
4,244
+264
+7% +$27.8K ﹤0.01% 526
2021
Q1 		$380K Buy
3,980
+632
+19% +$57.7K ﹤0.01% 485
2020
Q4 		$266K Buy
+3,348
New +$242K ﹤0.01% 500

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Wealthfront Advisers's TECH Position: Q2 2026 in Review

Wealthfront Advisers increased its Bio-Techne (TECH) stake by 11% in Q2 2026, buying an estimated $29.6K and bringing the position to 5,509 shares worth $389K. The position accounts for ﹤0.01% of the portfolio, ranked #932.

Wealthfront Advisers first reported a position in TECH in Q4 2020 and has held it in 13 quarters since. The position peaked at $1.91M in Q4 2021. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Wealthfront Advisers held 5,509 shares of Bio-Techne worth $389K as of Q2 2026.
  • Wealthfront Advisers bought 549 Bio-Techne shares in Q2 2026, an estimated $29.6K.
  • Bio-Techne made up ﹤0.01% of Wealthfront Advisers's portfolio in Q2 2026, its #932 holding.
  • Wealthfront Advisers first reported a position in Bio-Techne in Q4 2020 and has held it in 13 quarters since.
  • Wealthfront Advisers's Bio-Techne position peaked at $1.91M in Q4 2021.
  • 596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Wealthfront Advisers's 13F filing for Q2 2026, filed 7 Aug 2026.